Anti-Addiction Pills, Continued

The previous Childhood Obesity News post looked at some pills either shown or believed to have the potential to deal with compulsive overeating. A company called Adial developed a genetically targeted therapeutic agent that it believed could treat alcohol use disorder (AUD). The Phase 2 clinical trials showed “promising results in reducing frequency of drinking, quantity of drinking and heavy drinking… and no overt safety concerns.” As we have seen, bringing a new drug to the marketplace can take years. Earlier this year, Adial Pharmaceuticals announced that about one-third of Americans have the genetic makeup that responds to AD04, amounting to “a $36 billion potential market.” In some parts of the world, the proportion may be as high as half the population. In

from http://besthealthnews.com/2019/09/anti-addiction-pills-continued/?utm_source=rss&utm_medium=rss&utm_campaign=anti-addiction-pills-continued

from
https://healthnews010.tumblr.com/post/187504563923

from https://johnher1.blogspot.com/2019/09/anti-addiction-pills-continued.html

from
https://johnher10.tumblr.com/post/187504670417